Costa Rica rose to three doses complete scheme against Covid-19
Until now, the CNVE considered that the protective shield against the disease, caused by the SARS-CoV-2 coronavirus, was two doses of the products applied in this country -even combined- from Pfizer/BioNTech, AstraZeneca